市场调查报告书
商品编码
1308742
2030 年益生元市场预测 - 按成分、疾病类型、人口统计、最终用户和地区进行的全球分析Prebiotics Market Forecasts to 2030 - Global Analysis By Ingredients (Fructo-oligosaccharide, Inulin, Galacto-oligosaccharides and Other Ingredients), Disease Type, Demography, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球益生元市场规模将达到 82 亿美元,预测期内復合年增长率为 16.9%,预计到 2030 年将达到 246 亿美元。
益生元是不可消化的可溶性纤维,有助于结肠中有益细菌的生长。 益生元具有许多健康益处,包括改善人体免疫功能、消化功能以及控制血糖和胆固醇水平。 芦笋、菊苣根、大蒜和洋葱富含益生元。 益生元有多种用途,例如改善食品和饮料的质地或在不添加糖的情况下使其变甜。 此外,益生元还可以增加产奶量并帮助奶牛生长。
根据国家乳製品发展委员会 (NDDB) 的数据,到 2030 年,印度对乳製品的需求预计将达到 2.665 亿吨。
由于肠道健康益生元的消费量增加,益生元市场的收入正在增长。 益生元原材料被用于许多最终用途行业来製造糖替代品和低热量食品。 低聚果糖菊粉、低聚甘露聚醣 (MOS) 和低聚半乳糖 (GOS) 广泛应用于食品和饮料行业,对消化系统温和,促进肠道内有益细菌的生长,改善肠道健康。 益生元就像肥料一样,促进肠道内有益细菌的生长。 它存在于许多水果和蔬菜中,特别是那些含有膳食纤维和抗性淀粉的水果和蔬菜,它们是一种复杂的碳水化合物。
消费者对益生元产品的健康益处的认识不断下降,限制了市场的收入增长。 食品和饮料行业益生元产品的选择有限,部分原因是缺乏对食品和饮料产品中益生元成分的一般了解。 此外,消费者对益生元产品的好处的无知和缺乏有效的营销策略都限制了市场的增长。
随着消费者对含有较少糖和脂肪而不影响味道和质地的食品和饮料产品的需求,益生元和其他植物性低聚醣预计将越来越受欢迎。 随着肥胖率上升,市场预计将进一步扩大。 由于益生元能够促进益生菌和其他结肠细菌的生长并增强胃肠道和免疫系统功能,预计在预测期内对益生元的需求也会增加。
阻碍全球益生元市场增长的一个重要因素是过量服用益生元引起的腹泻、胃食管反流和腹痛等副作用。 预计在预测期内阻碍该市场增长的另一个因素是原材料价格的波动。
在新冠肺炎 (COVID-19) 疫情期间,对益生元补充剂的需求有所增加,因为消费者更喜欢增强免疫系统的补充剂。 食品、饮料和乳製品在任何商店都很容易买到,因此隔离期间需求很高。 然而,由于分销网络中断,益生元的销售陷入困境。
在预测期内,食品和饮料领域占据最大份额。 该细分市场的巨大市场份额主要归因于消费者健康意识的增强以及对益生元食品添加剂的需求增加。 此外,该细分市场的增长还受到人们引领健康和积极生活方式的趋势、食品和饮料行业新产品开发投资的增加以及对健康益处的认识的推动。
由于低聚半乳糖 (GOS) 的使用量不断增加,预计该细分市场在不久的将来将具有巨大的增长潜力。 此外,它还具有许多健康益处,包括通过促进钙吸收改善骨矿化、预防结肠癌、双歧桿菌生长和替代母乳低聚醣。
亚太地区的益生元市场份额最高。 影响亚太市场发展的主要因素之一是该地区知名领导者的存在。 由于该地区庞大的人口和充足的原奶供应将推动乳製品的扩张和消费,预计需求将会增加。 印度、中国和日本等国家是牛奶和乳製品的主要生产国,益生元被用于生产无糖、有质感的乳製品。 亚太地区益生元的供应量正在增加,益生元业务预计将在全球范围内增长。
猪流感和猪流行性腹泻病毒(PEDv)等危险动物疾病的发病率不断上升,增加了对动物饲料原料的需求,以防止危险病原体附着在肠道细胞中。预计欧洲将呈现最高的增长率预测期内全球益生元市场。 这正在增加该地区的市场收入。 此外,婴儿配方奶粉中益生元替代母乳正在推动市场扩张。
2023 年 5 月,嘉吉将在华盛顿州设立新工厂,扩大其零售饲料业务。 格兰杰的新零售饲料设施将扩大其现有的零售饲料足迹,使其能够更好地服务于太平洋西北地区的零售和农场和牧场客户。
2023 年 4 月,雅培宣布完成对 Cardioangio Systems, Inc. (CSI) 的收购,这是一家医疗器械公司,拥有用于治疗外周动脉和冠状动脉疾病的创新斑块切除系统。
2022 年 11 月,嘉吉与位于肯塔基州欧文斯伯勒的第五代家族大豆加工和精炼厂欧文斯伯勒谷物公司宣布嘉吉已达成最终协议。
According to Stratistics MRC, the Global Prebiotics Market is accounted for $8.2 billion in 2023 and is expected to reach $24.6 billion by 2030 growing at a CAGR of 16.9% during the forecast period. Prebiotics are soluble fibers that cannot be digested and help the growth of beneficial bacteria in the large intestine. Prebiotics have a number of health advantages, including improving immune and digestive function and controlling blood sugar and cholesterol levels in people. Asparagus, chicory root, garlic, onion, and other foods are high in prebiotics. Prebiotics have many uses, including improving the texture of food and beverages and giving them a sweeter taste without adding any sugar. Furthermore, prebiotics aid in boosting milk production and enhancing dairy animals' growth.
According to the National Dairy Development Board (NDDB), the demand in India is projected to reach 266.5 million metric tonnes for dairy products by 2030.
The prebiotic market is experiencing revenue growth as a result of rising prebiotic consumption for gut health. Prebiotic ingredients are used by numerous end-use industries to create sugar substitutes and low-calorie foods. Widely used in the food and beverage industry, FOS Inulin, Mannan-Oligosaccharide (MOS), and Galacto-Oligosaccharide (GOS) are gentle on the digestive system, encourage the growth of beneficial bacteria in the gut, and enhance gut health. Prebiotics promote the development of beneficial bacteria in the gut by acting as fertilizers. Many fruits and vegetables contain them, especially those that have fiber and resistant starch, which are examples of complex carbohydrates.
The decline in consumer awareness of the health advantages of prebiotic products is limiting market revenue growth. The food and beverage industry's limited selection of prebiotic products and the general lack of knowledge about the inclusion of prebiotic ingredients in food and beverage products are contributing factors. Additionally, consumers' ignorance of the advantages of prebiotic products and the lack of effective marketing strategies are both limiting market growth.
Prebiotics and other plant-based oligosaccharides are expected to become more popular as a result of growing consumer demand for food and drink products with lower sugar and fat contents without compromising taste or texture. The market is anticipated to grow even more as obesity rates rise. Demand for prebiotics is also anticipated to increase over the forecast period due to their ability to boost the growth of probiotics and other colon bacteria as well as enhance gastrointestinal and immune system functions.
A significant factor impeding the growth of the global prebiotics market is the side effects of taking prebiotics in excess, which include diarrhea, gastroesophageal reflux, and abdominal pain. Another factor that is anticipated to impede this market's growth over the forecast period is fluctuating raw material prices.
Due to consumers' preference for immune system-boosting supplements, demand for prebiotic supplements increased during COVID-19. Food, drinks, and dairy products are in higher demand during quarantine because they are readily available in all stores. However, the prebiotic's sales have suffered as a result of the logistical networks' disruption.
During the forecast period, the food and beverage segment held the largest share. The significant market share of this sector is primarily attributable to consumers' growing awareness of their health and the rising demand for prebiotic food additives. Additionally, the segment's growth is also being fueled by people's propensity for leading healthy, active lifestyles, rising investments in the development of new products in the food and beverage sector, and awareness of health benefits.
Due to the increasing usage of galactooligosaccharides (GOS), this segment is anticipated to hold significant growth potential in the near future. Furthermore, it has numerous health benefits, including improvement in bone mineralization by stimulating calcium absorption, prevention of colon cancer, growth of bifidobacteria, and replacement of human milk oligosaccharides.
The largest market share for prebiotics is expected to be held by Asia-Pacific. One of the primary factors influencing the development of the Asia-Pacific market is the presence of well-known leaders in the region. Due to the area's large population and abundant local milk supply, which are fostering the expansion and consumption of dairy products there, demand is anticipated to rise. Prebiotics are used in the production of dairy products that are sugar-free and have a better textural consistency in nations like India, China, and Japan, which are major producers of milk and milk products. The prebiotics business is expected to grow globally as a result of prebiotics' increasing utility in Asia-Pacific.
Due to the rising incidence of dangerous animal diseases like swine flu and porcine epidemic diarrhea virus (PEDv), which has fueled demand for animal feed ingredients to prevent dangerous pathogen adhesion in intestinal cells, Europe is predicted to experience the highest growth rate in the global prebiotics market during the forecast period. This is helping to boost market revenue in the region. Additionally, the substitution of prebiotics for breast milk in infant formulas is accelerating market expansion.
Some of the key players profiled in the Prebiotics Market include Abbott Laboratories, BENEO GmbH, Bright Food (Group) Corp. Ltd., Cargill Inc. ,Cosucra Groupe, Warcoing SA, FrieslandCampina, Jarrow Formulas, Inc., Kraft Foods Group, Inc., Parmalat S.p.A, Roquette Freres, Royal Cosun, The Kraft Heinz Company and Yakult Honsha Co., Ltd.
In May 2023, Cargill expands retail feed operation with plans for new facility in Washington state to service region's customers. The new Granger retail feed facility expands their existing retail feed footprint, enabling to better service the retail customers and their farm and ranch customers in the Pacific Northwestern region.
In April 2023, Abbott announced it has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
In November 2022, Cargill and Owensboro Grain Company, a fifth-generation family-owned soybean processing facility and refinery located in Owensboro, Ky., announced that they have entered into a definitive agreement where Cargill.
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.